Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

BACKGROUND: This study aimed to assess the characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background pain in comparison with patients receiving at least 60 mg of oral morphine equivalents (OME). MATERIALS AND METHODS: Patients with advanced cancer r...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Mercadante, Sebastiano, Caraceni, Augusto, Masedu, Francesco, Scipioni, Teresa, Aielli, Federica
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2019
Subjects:
Symptom Management and Supportive Care
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011660/
https://ncbi.nlm.nih.gov/pubmed/31862860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0542
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items